Pfaudler wins contract to equip Chinese pharmaceutical plant

Published: 18-Jul-2011
Manufacturing

With glass-lined reactor vessels and thermal control units

Pfaudler, a global supplier of glass lined reactors and modular process systems for the pharmaceutical industry, has won a contract to supply 43 glass-lined reactor vessels and nine thermal control units (TCUs) to a new pharmaceutical plant in Southern China. Financial details were not disclosed.

Pfaudler-Balfour, based in Leven, Fife, Scotland has designed the TCU heating and cooling systems (design range of -29/+200°C) in close consultation with Robbins & Myers Process Solutions Group company Suzhou Pfaudler, based in China, which is manufacturing glass-lined reactor vessels (ranging from 50 to 3000L) and building the TCUs.

Pfaudler says its design-build capability and proven track record helped secure this ‘significantly large order’ for process plant equipment.

With manufacturing sites in the UK, Germany, India, China, US, Mexico and Brazil, Pfaudler supplies modular systems that incorporate products and materials from the Robbins & Myers Process Solutions Group, including reactors, condensers, utility systems, columns, evaporators and heat exchangers.

See more

You may also like

Manufacturing

Pfaudler supplies two mobile reactors to UK pharma plant

Read more
They are being used for processing solvents, acids and alkalis

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
  3. UK REACH reform falls short as industry warns of £500m+ compliance bill The UK chemicals industry has condemned the Government's long-awaited response to the UK REACH Alternative Transitional Registration model consultation, arguing it does little to support growth or innovation
  4. Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
  5. Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Pfaudler supplies two mobile reactors to UK pharma plant

They are being used for processing solvents, acids and alkalis
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing

Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases

Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
Manufacturing

FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing

A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
Subscribe now